Acta Neurologica Scandinavica
Author Guidelines
1. SUBMISSION
Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/ane
Click here for more details on how to use ScholarOne.
Data protection
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.
Preprint policy
Please find the Wiley preprint policy here.
This journal accepts articles previously published on preprint servers.
Acta Neurologica Scandinavica will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
For help with submissions, please contact the Acta Neurologica Scandinavica Editorial Office: ANEoffice@wiley.com
2. AIMS AND SCOPE
Acta Neurologica Scandinavica aims to publish manuscripts of a high scientific quality representing original clinical, diagnostic or experimental work in neuroscience. The journal's scope is to act as an international forum for the dissemination of information advancing the science or practice of this subject area. Papers in English will be welcomed, especially those which bring new knowledge and observations from the application of therapies or techniques in the combating of a broad spectrum of neurological disease and neurodegenerative disorders. Relevant articles on the basic neurosciences will be published where they extend present understanding of such disorders. Priority will be given to review of topical subjects. Papers requiring rapid publication because of their significance and timeliness will be included as 'Clinical commentaries' not exceeding two printed pages, as will 'Clinical commentaries' of sufficient general interest. Debate within the specialty is encouraged in the form of 'Letters to the editor'. All submitted manuscripts falling within the overall scope of the journal will be assessed by suitably qualified referees.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
i. Original Articles
Word limit: 4,000 words maximum, excluding abstract, figure legends and references.
Abstract: 250 words maximum; must be structured, under the sub-headings: Objectives (including the aims of the study), Materials & Methods (if space is short, report only the primary outcomes), Results, Conclusions.
References: Maximum of 50 references.
Figures/Tables: Total of no more than 6 figures and tables.
Authors: Maximum of 10 authors.
ii. Review Articles
Word limit: 6,000 words maximum, excluding abstract, figure legends and references.
Abstract: 250 words maximum; unstructured summary.
References: Maximum of 80 references.
Figures/Tables: Total of no more than 8 figures and tables.
Authors: Maximum of 10 authors.
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/16000404/homepage/forauthors.html
